Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Michael McGoon"'
Autor:
Olivia Onyeador, Erika Berman Rosenzweig, Joel Wirth, Michael P. Gray, Murali Chakinala, Michael McGoon
Publikováno v:
Chest. 150:1176A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b1c6f250c1f1d012019cdb082fe1586
https://doi.org/10.1016/j.chest.2016.08.1285
https://doi.org/10.1016/j.chest.2016.08.1285
Autor:
Roham T. Zamanian, Kristina Kudelko, Dave P. Miller, Leslie Meltzer, Michael McGoon, Raymond L. Benza, Paul M. Hassoun, Mark R. Nicolls, Lorinda Chung
Publikováno v:
B107. BIOMARKERS AND PREDICTORS OF OUTCOMES IN PULMONARY HYPERTENSION.
Background: Change in diffusing capacity for carbon monoxide (DLCO) is a more powerful predictor of outcomes than baseline DLCO in connective tissue disease (CTD)-associated pulmonary arterial hypertension (PAH). Aims and Objectives: We sought to val
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8150f3e2d7511cff43fd716af3d1fdcc
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3836
https://doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3836
Autor:
David B, Badesch, Jeremy, Feldman, Anne, Keogh, Michael A, Mathier, Ronald J, Oudiz, Shelley, Shapiro, Harrison W, Farber, Michael, McGoon, Adaani, Frost, Martine, Allard, Darrin, Despain, Christopher, Dufton, Lewis J, Rubin, F, Witherspoon
Publikováno v:
Cardiovascular therapeutics. 30(2)
Ambrisentan is an oral, once daily, endothelin receptor antagonist approved for treatment of pulmonary arterial hypertension (PAH). Previous studies of ambrisentan were limited to patients with Group 1 PAH and often excluded patients receiving other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::643b73b19ff9aff9f9465ef0fea5be48
https://pubmed.ncbi.nlm.nih.gov/21884013
https://pubmed.ncbi.nlm.nih.gov/21884013
Autor:
Lorinda, Chung, Juliana, Liu, Lori, Parsons, Paul M, Hassoun, Michael, McGoon, David B, Badesch, Dave P, Miller, Mark R, Nicolls, Roham T, Zamanian
REVEAL (the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management) is the largest US cohort of patients with pulmonary arterial hypertension (PAH) confirmed by right-sided heart catheterization (RHC), providing a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5e578256014a52cd7f263d094f459143
https://europepmc.org/articles/PMC3621419/
https://europepmc.org/articles/PMC3621419/
Autor:
Michael, McGoon, David, Gutterman, Virginia, Steen, Robin, Barst, Douglas C, McCrory, Terry A, Fortin, James E, Loyd
Publikováno v:
Chest. 126
Pulmonary arterial hypertension (PAH) occurs as an idiopathic process or as a component of a variety of disease processes, including chronic thromboembolic disease, connective tissue diseases, congenital heart disease, and exposure to exogenous facto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d26115bbdc25a2ff2a8c56612353ff5d
https://pubmed.ncbi.nlm.nih.gov/15249493
https://pubmed.ncbi.nlm.nih.gov/15249493
Autor:
Michael McGoon
Publikováno v:
Advances in Pulmonary Hypertension. 3:3-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc183a0819a2a1d3c9fafeb483fceb24
https://doi.org/10.21693/1933-088x-3.3.3a
https://doi.org/10.21693/1933-088x-3.3.3a
Autor:
Robyn J, Barst, Michael, McGoon, Vallerie, McLaughlin, Victor, Tapson, Stuart, Rich, Lewis, Rubin, Karlman, Wasserman, Ronald, Oudiz, Shelley, Shapiro, Ivan M, Robbins, Richard, Channick, David, Badesch, Barry K, Rayburn, Robin, Flinchbaugh, Jeff, Sigman, Carl, Arneson, Roger, Jeffs
Publikováno v:
Journal of the American College of Cardiology. (12):2119-2125
ObjectivesThe purpose of this study was to assess the safety and efficacy of the oral prostacyclin analogue beraprost sodium during a 12-month double-blind, randomized, placebo-controlled trial in patients with pulmonary arterial hypertension (PAH).B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c279ea1fefd8ba2f25c879039a15b6